2019
DOI: 10.1016/j.yjmcc.2019.04.014
|View full text |Cite
|
Sign up to set email alerts
|

The assembly and evaluation of antisense oligonucleotides applied in exon skipping for titin-based mutations in dilated cardiomyopathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 23 publications
0
5
0
Order By: Relevance
“…This finding is intriguing, because genetic variations in titin A-band are the leading cause of DCM [62,63]. Hence, based on our finding, it is not unreasonable to speculate that dysregulated splicing of Titin antisense 1 might be able to induce deleterious exon-skipping in the A-band of titin, which may mimic the pathologies seen in TTNtv, and that modification of this region might even be a therapeutic principle [64,65]. Hence, the current study provides new understanding of the regulation of this important gene locus.…”
Section: Discussionmentioning
confidence: 76%
“…This finding is intriguing, because genetic variations in titin A-band are the leading cause of DCM [62,63]. Hence, based on our finding, it is not unreasonable to speculate that dysregulated splicing of Titin antisense 1 might be able to induce deleterious exon-skipping in the A-band of titin, which may mimic the pathologies seen in TTNtv, and that modification of this region might even be a therapeutic principle [64,65]. Hence, the current study provides new understanding of the regulation of this important gene locus.…”
Section: Discussionmentioning
confidence: 76%
“…The measurement of drain conductance current (I DS ) with changing V GS was used in the calculation of the intrinsic transconductance, g m = ΔI DS /ΔV GS and OECT characteristic curves were plotted using Origin software HL-1 Cell Culture: HL-1 cells were kindly provided by M. Gramlich (RWTH Aachen, Germany) and cultured according to published protocols in Claycomb medium (51800C, Sigma-Aldrich, Germany) supplemented with 10% fetal bovine serum (FBS) (v/v) (Eurobio, Courtaboeuf, France), 100 U mL −1 penicillin and 0.01% (w/v) streptomycin (Invitrogen, Saint Aubin, France), 0.1 mm norepinephrine (Sigma-Aldrich, Germany), and 2 mm L-glutamine (EMD Millipore, Germany). [28,54] The chip surface was coated at 37 °C for 1 h with 0.02% w/v gelatine (EMD Millipore, Germany) and 0.1% w/v fibronectin (F-1141, Sigma-Aldrich, German). Cells were seeded as 50 000 cells/chip and electrophysiological recordings were performed 6 days later at confluency.…”
Section: Methodsmentioning
confidence: 99%
“…The first is the use of antisense oligonucleotides (ASOs) to promote skipping of variant-containing exons has been explored as a potential strategy to treat pathogenic variants in titin that cause DCM ( Gramlich et al, 2015 ). ASO-mediated strategies have shown promise in both mice and cultured cells ( Gramlich et al, 2015 ; Hahn et al, 2019 ). Given that ASOs have already been approved for the treatment of other diseases ( Crooke et al, 2021 ), such as Duchenne’s muscular dystrophy, ASO-based exon skipping strategies represent an accessible strategy to treat DCM caused by certain disruptive variants in titin.…”
Section: Future Perspectives: Targeting Titin In Heart Diseasementioning
confidence: 99%